Novo Integrated Sciences, Inc.
NVOS Healthcare Medical Care Facilities
Novo Integrated Sciences, Inc.’s revenue for fiscal 2024 (year ended August 2024) was $13.3 million, up 5.75% from fiscal 2023. Revenue growth for five consecutive years.
Follow NVOS
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Aug '24 | May '24 | Feb '24 | Nov '23 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
0.84 | 1.54 | 0.65 | 1.64 |
+8 more quarters Free account |
Receivables |
3.15 | 3.30 | 3.20 | 3.68 | |
Inventory |
1.00 | 1.11 | 0.95 | 1.27 | |
Total current assets |
5.41 | 6.16 | 5.02 | 6.81 | |
Property, Plant, Equpment (Net) |
5.11 | 5.16 | 5.25 | 5.31 | |
Goodwill and Intangible Assets (Total) |
19.92 | 22.21 | 22.77 | 23.26 | |
Total non-current assets |
26.73 | 29.17 | 29.93 | 30.44 | |
Total Assets |
32.14 | 35.33 | 34.95 | 37.24 | |
Notes Payable |
2.70 | 1.22 | 1.77 | 1.10 | |
Accounts Payable |
3.24 | 3.89 | 2.17 | 3.40 | |
Accrued Expenses |
2.22 | 1.78 | 1.81 | 1.78 | |
Current Part of Debt |
0.96 | 1.00 | 1.01 | 1.01 | |
Current Part of Capital Lease |
0.00 | 0.00 | 0.01 | 0.01 | |
Other current liabilities |
5.06 | 14.36 | 2.77 | 3.20 | |
Total current liabilities |
14.58 | 22.68 | 9.96 | 10.92 | |
Long Term Debt (Total) |
0.11 | 0.06 | 0.06 | 0.06 | |
Long Term Tax Liability (Deferred) |
1.40 | 1.39 | 1.40 | 1.40 | |
Total non-current liabilities |
2.95 | 2.99 | 3.10 | 3.04 | |
Total liabilities |
17.53 | 25.66 | 13.06 | 13.96 | |
Additional Paid In Capital |
96.66 | 96.66 | 96.08 | 95.48 | |
Common Stock (Net) |
0.02 | 0.02 | 0.02 | 0.02 | |
Retained Earnings |
(83.20) | (88.20) | (74.46) | (71.71) | |
Shareholders Equity (Other) |
0.03 | 0.03 | 0.04 | 0.04 | |
Common Equity (Total) |
14.61 | 9.66 | 21.89 | 23.28 | |
Shareholders Equity (Total) |
14.61 | 9.66 | 21.89 | 23.28 | |
Shareholders Equity and Liabilities (Total) |
32.14 | 35.33 | 34.95 | 37.24 | |
Shares (Common) |
19.05 | 19.06 | 17.75 | 17.29 | |
Shareholders Equity (Tangible) |
(5.31) | (12.55) | (0.88) | 0.03 | |
Net Debt |
0.23 | (0.47) | 0.42 | (0.57) | |
Total Debt |
1.07 | 1.07 | 1.07 | 1.07 |